Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Abroad (travel likely)Recruiting

Conditions

Immunoglobulin Prophylaxis · Cytomegalovirus Infections · Allogeneic Hematopoietic Stem Cell Transplantation · Transplant-Related Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

IRCCS Burlo Garofolo, Trieste, Italy
Contact: Study coordinator (Natalia Maximova, MD) · natalia.maximova@burlo.trieste.it
Debora Curci, PhD (Sub-investigator)

Study leads

Natalia Maximova, MD
Principal Investigator
IRCCS Burlo Garofolo - Trieste - ITALY

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Cytomegalovirus · Organ Transplant · Kidney Transplant; Complications

Abroad (travel likely)RecruitingPHASE4

Boston, United States · Dallas, United States